183 related articles for article (PubMed ID: 28288979)
41. Associations between elevated pre-treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphoma.
Binder M; O'Byrne MM; Maurer MJ; Ansell S; Feldman AL; Cerhan J; Novak A; Porrata LF; Markovic S; Link BK; Witzig TE
Am J Hematol; 2017 Aug; 92(8):752-758. PubMed ID: 28383112
[TBL] [Abstract][Full Text] [Related]
42. Germline variation in the 3'-untranslated region of the POU2AF1 gene is associated with susceptibility to lymphoma.
Zhai K; Chang J; Hu J; Wu C; Lin D
Mol Carcinog; 2017 Aug; 56(8):1945-1952. PubMed ID: 28345816
[TBL] [Abstract][Full Text] [Related]
43. High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression.
Maura F; Guidetti A; Pellegrinelli A; Dodero A; Pennisi M; Caprioli C; Testi A; Farina L; Bolli N; Devizzi LF; Cabras A; Corradini P
Blood Cancer J; 2017 Mar; 7(3):e544. PubMed ID: 28304403
[No Abstract] [Full Text] [Related]
44. Precision medicine and lymphoma.
Heward JA; Kumar EA; Korfi K; Okosun J; Fitzgibbon J
Curr Opin Hematol; 2018 Jul; 25(4):329-334. PubMed ID: 29738334
[TBL] [Abstract][Full Text] [Related]
45. Germinal center-derived lymphomas: The darkest side of humoral immunity.
Mlynarczyk C; Fontán L; Melnick A
Immunol Rev; 2019 Mar; 288(1):214-239. PubMed ID: 30874354
[TBL] [Abstract][Full Text] [Related]
46. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Schmitz R; Wright GW; Huang DW; Johnson CA; Phelan JD; Wang JQ; Roulland S; Kasbekar M; Young RM; Shaffer AL; Hodson DJ; Xiao W; Yu X; Yang Y; Zhao H; Xu W; Liu X; Zhou B; Du W; Chan WC; Jaffe ES; Gascoyne RD; Connors JM; Campo E; Lopez-Guillermo A; Rosenwald A; Ott G; Delabie J; Rimsza LM; Tay Kuang Wei K; Zelenetz AD; Leonard JP; Bartlett NL; Tran B; Shetty J; Zhao Y; Soppet DR; Pittaluga S; Wilson WH; Staudt LM
N Engl J Med; 2018 Apr; 378(15):1396-1407. PubMed ID: 29641966
[TBL] [Abstract][Full Text] [Related]
47. Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma.
Meyer SN; Scuoppo C; Vlasevska S; Bal E; Holmes AB; Holloman M; Garcia-Ibanez L; Nataraj S; Duval R; Vantrimpont T; Basso K; Brooks N; Dalla-Favera R; Pasqualucci L
Immunity; 2019 Sep; 51(3):535-547.e9. PubMed ID: 31519498
[TBL] [Abstract][Full Text] [Related]
48. TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.
Venturutti L; Teater M; Zhai A; Chadburn A; Babiker L; Kim D; Béguelin W; Lee TC; Kim Y; Chin CR; Yewdell WT; Raught B; Phillip JM; Jiang Y; Staudt LM; Green MR; Chaudhuri J; Elemento O; Farinha P; Weng AP; Nissen MD; Steidl C; Morin RD; Scott DW; Privé GG; Melnick AM
Cell; 2020 Jul; 182(2):297-316.e27. PubMed ID: 32619424
[TBL] [Abstract][Full Text] [Related]
49. CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma.
Xian RR; Xie Y; Haley LM; Yonescu R; Pallavajjala A; Pittaluga S; Jaffe ES; Duffield AS; McCall CM; Gheith SMF; Gocke CD
Blood Cancer J; 2020 Jun; 10(6):69. PubMed ID: 32555149
[TBL] [Abstract][Full Text] [Related]
50. M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy.
Lockmer S; Ren W; Brodtkorb M; Østenstad B; Wahlin BE; Pan-Hammarström Q; Kimby E
Br J Haematol; 2020 Jan; 188(2):259-267. PubMed ID: 31423576
[TBL] [Abstract][Full Text] [Related]
51. Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.
Gonzalez-Farre B; Ramis-Zaldivar JE; Salmeron-Villalobos J; Balagué O; Celis V; Verdu-Amoros J; Nadeu F; Sábado C; Ferrández A; Garrido M; García-Bragado F; de la Maya MD; Vagace JM; Panizo CM; Astigarraga I; Andrés M; Jaffe ES; Campo E; Salaverria I
Haematologica; 2019 Sep; 104(9):1822-1829. PubMed ID: 30733272
[TBL] [Abstract][Full Text] [Related]
52. Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016.
Qu X; Li H; Braziel RM; Passerini V; Rimsza LM; Hsi ED; Leonard JP; Smith SM; Kridel R; Press O; Weigert O; LeBlanc M; Friedberg JW; Fang M
Blood; 2019 Jan; 133(1):81-93. PubMed ID: 30446494
[TBL] [Abstract][Full Text] [Related]
53. Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles.
Hellmuth JC; Louissaint A; Szczepanowski M; Haebe S; Pastore A; Alig S; Staiger AM; Hartmann S; Kridel R; Ducar MD; Koch P; Dreyling M; Hansmann ML; Ott G; Rosenwald A; Gascoyne RD; Weinstock DM; Hiddemann W; Klapper W; Weigert O
Blood; 2018 Oct; 132(16):1695-1702. PubMed ID: 30126979
[TBL] [Abstract][Full Text] [Related]
54.
Jia D; Augert A; Kim DW; Eastwood E; Wu N; Ibrahim AH; Kim KB; Dunn CT; Pillai SPS; Gazdar AF; Bolouri H; Park KS; MacPherson D
Cancer Discov; 2018 Nov; 8(11):1422-1437. PubMed ID: 30181244
[No Abstract] [Full Text] [Related]
55. Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expression.
Sun Y; Chen J; Hong JH; Xiao R; Teng Y; Wang P; Deng P; Yu Z; Chan JY; Chai KXY; Gao J; Wang Y; Pan L; Liu L; Liu S; Teh BT; Yu Q; Lim ST; Li W; Xu B; Ong CK; Tan J
Oncogene; 2024 May; ():. PubMed ID: 38783101
[TBL] [Abstract][Full Text] [Related]
56. Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment.
Li J; Chin CR; Ying HY; Meydan C; Teater MR; Xia M; Farinha P; Takata K; Chu CS; Jiang Y; Eagles J; Passerini V; Tang Z; Rivas MA; Weigert O; Pugh TJ; Chadburn A; Steidl C; Scott DW; Roeder RG; Mason CE; Zappasodi R; Béguelin W; Melnick AM
Nat Commun; 2024 Apr; 15(1):2879. PubMed ID: 38570506
[TBL] [Abstract][Full Text] [Related]
57. Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphoma.
Merryman RW; Rhoades J; Xiong K; Redd RA; Antel K; An HH; McDonough M; Guerrero L; Crnjac A; Sridhar S; Blewett T; Cheng J; Dahi PB; Nieto Y; Joyce RM; Chen YB; Herrera AF; Armand P; Murakami M; Adalsteinsson VA
Hemasphere; 2024 Apr; 8(4):e47. PubMed ID: 38566803
[No Abstract] [Full Text] [Related]
58. Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin Lymphoma.
Santisteban-Espejo A; Bernal-Florindo I; Montero-Pavon P; Perez-Requena J; Atienza-Cuevas L; Fernandez-Valle MDC; Villalba-Fernandez A; Garcia-Rojo M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473705
[TBL] [Abstract][Full Text] [Related]
59. Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis.
Wallace L; Obeng EA
Front Mol Biosci; 2023; 10():1273046. PubMed ID: 38028538
[TBL] [Abstract][Full Text] [Related]
60. Modeling the crosstalk between malignant B cells and their microenvironment in B-cell lymphomas: challenges and opportunities.
Brauge B; Dessauge E; Creusat F; Tarte K
Front Immunol; 2023; 14():1288110. PubMed ID: 38022603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
